Marker Therapeutics, Inc.
MRKR
$1.03
-$0.07-6.36%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -9.70M | -10.37M | -5.66M | -8.24M | -9.29M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 338.70K | 200.20K | -9.58M | -11.05M | -12.20M |
| Change in Net Operating Assets | 783.30K | -729.40K | 856.10K | 2.85M | 1.11M |
| Cash from Operations | -8.57M | -10.90M | -14.39M | -16.44M | -20.38M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 18.78M | 18.66M | 18.54M |
| Cash from Investing | 0.00 | 0.00 | 18.78M | 18.66M | 18.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 100.50K | 578.10K | 534.20K | 1.11M | 1.24M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.50K | 578.10K | 534.20K | 1.11M | 1.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.47M | -10.32M | 4.92M | 3.33M | -602.50K |
